[Intragastric pH modifications induced by antisecretory treatments].
Vallot
T
T
Service d'Hépato-Gastroentérologie, Centre Hospitalo-Universitaire Bichat-Claude Bernard, Paris.
Galmiche
J P
JP
Gouilloud-Celle
S
S
Mignon
M
M
D004381:Duodenal Ulcer / Q000188:drug therapy / Q000503:physiopathology; D004941:Esophagitis / Q000503:physiopathology; D005745:Gastric Acidity Determination; D005764:Gastroesophageal Reflux / Q000503:physiopathology; D006635:Histamine H2 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009853:Omeprazole / Q000009:adverse effects* / Q000627:therapeutic use; D010276:Parasympatholytics / Q000009:adverse effects* / Q000627:therapeutic use; D012016:Reference Values; D013276:Stomach Ulcer / Q000503:physiopathology; D014628:Vagotomy / Q000009:adverse effects
D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D009853:Omeprazole
Modifications du pH gastrique induites par les traitements anti-sécrétoires.